Hospital
Great Plains of Smith Co., INC.
Great Plains of Smith Co., INC. was paid $13K by Medicaid between Jan 2018 and Jul 2024, across 9 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 41% of everything it billed.
33Billing provider infoGREAT PLAINS OF SMITH CO., INC.
SMITH CENTER, KS 66967
SMITH CENTER, KS 66967
33aNPI1700985116assigned 09/22/2006
33bProvider typeCritical Access Hospital
28Total paid$13K
24GClaims2,291
24DCodes billed9
24AFirst – last monthJan 2018 – Jul 2024
Compared with peers
Next to other Critical Access Hospital providers in Kansas
Rank by total paid#33 of 74
Median peer was paid$11K
This provider vs. median1.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 263 | $2K | |
| 2019 | 211 | $2K | |
| 2020 | 280 | $1K | |
| 2021 | 128 | $444.78 | |
| 2022 | 636 | $4K | |
| 2023 | 560 | $2K | |
| 2024incomplete | 213 | $616.11 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 41% | 520 | 456 | $5K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 26% | 138 | 121 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 20% | 569 | 505 | $2K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 12% | 33 | 28 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.2% | 13 | 13 | $152.28 |
| 81003 | <1% | 20 | 16 | $46.86 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 970 | 810 | $20.08 |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 0% | 13 | 13 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 15 | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRAGSDALE, SARAH (CEO)
Parent organizationGREAT PLAINS OF SMITH CO., INC.
| Provider | Location | Paid |
|---|---|---|
| Great Plains of Smith Co., INC. | Smith Center, KS | $1.83M |
| Great Plains of Smith Co., INC. | Smith Center, KS | $306.46 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.